<DOC>
	<DOCNO>NCT01404377</DOCNO>
	<brief_summary>Prospective double blind randomized evaluation effect surgical wound infiltration ropivacaine versus placebo patient schedule breast surgery axillary lymph node dissection</brief_summary>
	<brief_title>Wound Infiltration Breast Cancer Surgery</brief_title>
	<detailed_description>This prospective , double-blind , randomize , single centre study Adult ASA I - II patient , schedule unilateral mastectomy tumorectomy associate axillary lymph node dissection include study . Patients receive opioid analgesic treatment chronic pain surgery , patient know allergy local anaesthetic , patient acquire genetic haemostatic abnormality exclude . Patients allocate randomly two group morning surgery , use random number seal envelope . general anaesthesia use propofol sufentanil induction , sevoflurane In treated group infiltration perform ropivacaine 7.5 mg.ml-1 solution control group isotonic saline solution . In two group patient operate general anesthesia propofol , sufentanil , sevoflurane nitrous oxide maintenance . Twenty milliliter allocate solution use end surgical procedure infiltrate subcutaneous deep layer level breast axilla surgical incision . Postoperatively , 8 tablet paracetamol 500 mg let patient ' disposal every 24 hour 3 day . If pain control adequate patient receive 5 mg subcutaneous morphine rescue . Pain intensity measure visual analogue scale grade 0 100 . Measurements perform rest operate arm abduction , 2 , 4 , 6 , 12 , 24 , 48 , 72 hour end surgery . The value maximum abduction angle note . To evaluate quality life patient ask score 4 point scale grade 0 ( bad ) 3 ( best ) follow item : sleep - fatigue - global activity - relationship relatives - state mood . A global score attribute patient sum categorical score . Evaluation perform 24 , 48 72 hour end surgery . Patients evaluate two month residual pain rest movement use visual analogue scale quality life previously define .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>Adult ASA I II patient , schedule unilateral mastectomy tumorectomy associate axillary lymph node dissection Patients receive opioid analgesic treatment chronic pain surgery , patient know allergy local anaesthetic , patient acquire genetic haemostatic abnormality</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>breast surgery : postoperative pain ; ropivacaine</keyword>
</DOC>